Professional Documents
Culture Documents
Trial Exam 2022 (Dr. Safaa)
Trial Exam 2022 (Dr. Safaa)
Trial Exam 2022 (Dr. Safaa)
2)
3)
4)
Augmentin
5
EXAM
)
6)
Because antihypertensives
are potent drugs
(NOT formulated as powders)
9 EXAM
10 EXAM
11
a) decrease in porosity
b) Increase in bulkiness
c) Decrease in density
15
16 EXAM
17
18
EXAM
19
20
EXAM
21
22
23
24 EXAM
25
26
EXAM
27
EXAM
EXAM
28
29
32 EXAM
a) Occurs during storage of suspensions prepared using the stable form of a drug
b) Has no effect on particle size distribution
c) Is prevented by using the unstable polymorph of a drug
d) Occurs during storage of suspensions prepared using metastable form of a drug
34
EXAM
35
36
EXAM
37
2021 Exam
1) The B.P. classification for particle size of powders using sieving technique can be used for all of
the following EXCEPT ……………… powders
a) Moderately fine
b) Moderately coarse
c) Super fine
d) Fine
EXAM
2) Concerning ICH guidelines , which of the following is NOT TRUE ?
a) Particle size specification is established only for soluble drugs due to concern of bioavailability
b) Guidelines is needed if the particle size of the drug is critical to bioavailability
c) Guidelines is needed if the particle size of the drug affects the flowability
d) Particle size specification is established only for poorly soluble drugs due to concern of content
uniformity
3) B.P. recommends uniformity of content test for the following powder , EXCEPT ………
a) Oral powders with active ingredient less than 2 mg/dose
b) Oral powders with active ingredient less than 2% of total mass
c) Topical powders with active ingredient less than 2 mg/dose
d) Oral dry herbal powders
6) Frequency distribution curve for powders , all of the following is true except …………….
a) If it is positively skewed curve , the mode has small value
b) If it is positively skewed curve , the mode has large value
c) If it is negatively skewed curve , the mode has large value
d) In normal frequency distribution , the mode has intermediate value
b) Sv = d) Sw =
13) Compression
a) Decrease surface area and tablet hardness EXAM
b) Decrease the particles' densities
c) Decrease the granule volume of porous powders
d) Decrease the disintegration time
14) In tablet manufacture & capsule filling , the following is NOT true
a) Compressibility of powders is more than 40
b) Compressibility of powders is 18 - 21
c) Elimination of fines by granulation
d) Enhance the flow properties by granulation
15) Particle size analysis by sedimentation technique can be used for the following EXCEPT
a) Dilute suspensions (1 – 2%) c) Colloidal dispersions
b) Deflocculated suspensions d) When Reynold's no. is more than 0.2
EXAM
16) FDA guide to inspection of oral dosage forms is important …………….. (EXAM)
a) For pre/post approval issues for development and validation
b) For demonstration of bioequivalence between batches
c) When the processes of manufacture are modified or changed
d) All of the above
18) The following diameters are obtained from Edmundson's equation ………… EXAM
a) Harmonic mean diameter , when P is positive
b) Geometric mean diameter , when P is negative
c) Length arithmetic mean diameter , when P is positive , its value is 1
d) Length arithmetic mean diameter , when P is zero
20) Controlling the particle size , accurate metering of the dose is the main requirement for …..
a) Oral preparation containing potent drug
b) Powder for cutaneous application
c) Insufflation
d) Powders for injection
23. The sterility tests is carried out for the following EXAM
24) The following method used for particle size analysis is affected by particle shape EXAM
a) Optical microscopy
b) Sedimentation
c) Sieving
d) Laser light scattering
27) Adducts :
a) Are pseudopolymorphic forms
EXAM
b) Affect flow properties and compressibility of powders
c) Are Occlusion solvates
d) Are amorphous
EXAM
29-Which of the following is TRUE:
a- Adducts result from association of Solvent molecules with drug during crystallization
b- Pseudopolymorphs are formed due to presence of solvent in the unit structure of crystal
c- Occlusion solvates show no association of solvent molecules during crystallization
d- pseudopolymorphism result from association of solvent molecules with drug during crystallization
Important notes :